The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products.


Updates from The Motley Fool

Latest updates on GlaxoSmithKline from Fool.com.  The Fool has written over 900 articles on GlaxoSmithKline.
My 3 Biggest Stock Holdings

AT&T, GlaxoSmithKline, and Bank of America’s Series D Preferred Stock are the three top holdings ...



Stock Performance

View Interactive GSK Charts
Sponsored by

Key Data Points

Primary metrics and data points about GlaxoSmithKline.
Current Price: $41.49
Prev Close: $41.03
Open: $41.26
Bid: $41.00
Ask: $41.64
Day's Range: $41.16 - $41.60
52wk Range: $37.20 - $45.58
Volume: 2,855,500
Avg Vol 3,815,224
Market Cap: $101B
P/E (ttm): 23.58
EPS (ttm): $0.00
Div & Yield: $2.30 (4.8%)

Company Rating

What our community thinks about GlaxoSmithKline.
CAPS Rating 3 out of 5
 
1418 Outperform
85 Underperform
CAPS All Stars
 
336 Outperform
19 Underperform

How do you think GlaxoSmithKline will perform against the market?



You pick for GlaxoSmithKline is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Andrew Witty, CEO

76% Approve

Based on 777 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for GlaxoSmithKline.

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers